RNAi potency prediction method

Details for Australian Patent Application No. 2004298527 (hide)

Owner Novartis AG

Inventors Natt, Francois Jean-Charles; Huesken, Dieter; Hall, Jonathan; Lange, Jorg Bernd; Reinhardt, Mischa Werner Henri Marie

Agent Davies Collison Cave

Pub. Number AU-A-2004298527

PCT Pub. Number WO2005/059132

Priority 60/528,430 10.12.03 US

Filing date 9 December 2004

Wipo publication date 30 June 2005

International Classifications

G06F 19/00 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific applications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/059132 Priority application(s): WO2005/059132

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004298530-Pathogenic bovine enterovirus, vaccines, and diagnostic methods

2004298525-Process for applying a coating to a coiled metal sheet